Back to comparisons

Comparison

Aniracetam vs Alpha-GPC

FieldAniracetamAlpha-GPC
Categoryracetamcholinergic
Dose range750–1500mg300–600mg
Half-life2h6h
Onset30min30min
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●
Legal (US)USUnscheduledUSOTC
PubMed refs280320

The comparison in plain English

Auto-generated from data

Aniracetam and Alpha-GPC are both in the racetam (racetam) and cholinergic respectively. Aniracetam A fat-soluble racetam ~5-10x more potent than piracetam. Alpha-GPC The most bioavailable common choline source.

Bottom line

Aniracetam (evidence B, safety 4/5) has a stronger evidence base than Alpha-GPC (evidence A, safety 5/5). Alpha-GPC has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Aniracetam if

Aniracetam is the better fit when your goal aligns with its mechanism (Positive allosteric modulator of AMPA receptors, slowing receptor desensitisation and prolonging excitatory signalling) and the dose range (750–1500mg) suits your protocol. Half-life is 2h.

Choose Alpha-GPC if

Alpha-GPC is the better fit when your goal aligns with its mechanism (Rapidly absorbed and cleaved into choline and glycerophosphate) and the dose range (300–600mg) suits your protocol. Half-life is 6h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →